Global Cell And Gene Therapy Manufacturing Market By Therapy Type (Cell therapy, Gene therapy) By Mode (In-house Manufacturing, Contract Manufacturing (CDMOs & CMOs)) By Scale (Preclinical and Clinical-Scale, Commercial-Scale) By Application (Oncology (Cancer Treatment), Neurological Disorders, Cardiovascular Diseases, Rare & Genetic Disorders, Infectious Diseases, Musculoskeletal Disorders, Autoimmune Diseases, Other Applications) By End-user (Pharmaceutical & Biotechnology Companies, Contract Development & Manufacturing Organizations (CDMOs/CMOs), Research Institutes & Academic Organizations, Hospitals & Clinics) By Region and Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends, and Forecast 2025-2034
Report Overview Global Cell And Gene Therapy Manufacturing Market size is expected to be worth around US$ 60.3 Billion by 2034 from US$ 6.9 Billion in 2024, growing at a CAGR of 24.3...
